{"id":"W4285606218","doi":"10.1016/j.eururo.2022.06.009","title":"Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Sunitinib; Axitinib; Renal cell carcinoma; Pembrolizumab; Internal medicine; Kidney cancer; Quality of life (healthcare); Hazard ratio; Oncology; Adverse effect; Cancer; Confidence interval; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002577767,0.0007926105,0.00222189,0.0004649076,0.0002031132,0.0008419385,0.0007745314,0.0005830826,0.006074694],"category_scores_gemma":[0.002499965,0.0002804234,0.005718858,0.0005884006,0.0003412355,0.0007413819,0.0006252889,0.00208309,0.0004065328],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008243545,"about_ca_system_score_gemma":0.0008703339,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002244987,"about_ca_topic_score_gemma":0.003173962,"domain_scores_codex":[0.9988334,0.0006011563,0.00006841424,0.0001681925,0.000133901,0.0001949249],"domain_scores_gemma":[0.9988375,0.0006015137,0.0002200721,0.00007162398,0.00006539281,0.0002039582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8810977,0.004203672,0.01746372,0.00157112,0.02251915,0.0001524361,0.00007019593,0.01621443,0.005953631,0.0002785248,0.004412388,0.04606299],"study_design_scores_gemma":[0.2811938,0.2612343,0.3548256,0.0004608164,0.05517262,0.0006568603,0.0003958769,0.02955288,0.006615221,0.001587282,0.008073947,0.0002308759],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892608,0.003007908,0.0004103622,0.0003083461,0.00009245455,0.0002274537,0.004812084,0.00003142801,0.00184907],"genre_scores_gemma":[0.9936973,0.0006047134,0.000420014,0.0002022567,0.00007486462,0.0001277845,0.003910157,0.00001405985,0.0009488107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006074694,"threshold_uncertainty_score":0.02032191,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05936434309129127,"score_gpt":0.3011600521554575,"score_spread":0.2417957090641662,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}